Go to Samples

AstraZeneca Pharmaceuticals LP
Calquence
Oncology
Indications and Usage
Mantle Cell Lymphoma
CALQUENCE is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
This indication is approved under accelerated approval based on overall response rate [see Clinical Studies (14.1)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
CALQUENCE is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows















HOW IT WORKS
The easy way to access samples
Create Free AccountRequest, track, and manage samples from multiple brands
Connect with a RepHave access to pharma representatives in one place to request your samples
Get your SampleManage your reps and samples in one place
WHO IS PRESCRIBERPOINT
Increasing patient access to medications they need
At PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.200K+Visitors Each Month
100K+Engagements Each Month
1M+Resources Viewed
WHAT HCPS ARE SAYING
FAQs
All you need to know to order samples
Currently, PrescriberPoint is available only in the U.S, but we are excited to expand our reach in the future! Stay connected by following us or signing up for our newsletter to get the latest updates, including announcements about new market launches.